Evidence map›Paper›PMID 42638411›Full record

ArticleJournal of cellular and molecular medicine2026

RETRACTION: Salvianolic Acid B-Induced MicroRNA-152 Inhibits Liver Fibrosis by Attenuating DNMT1-Mediated Patched1 Methylation.

Abstract readRetraction Notice
In one paragraph

Article in Journal of cellular and molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

0 authors.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

retractionF. Yu, Z. Lu, B. Chen, X. Wu, P. Dong, and J. Zheng, "Salvianolic Acid B-Induced MicroRNA-152 Inhibits Liver Fibrosis by Attenuating DNMT1-Mediated Patched1 Methylation," Journal of Cellular and Molecular Medicine 19, no. 11 (2015): 2617-2632, https://doi.org/10.1111/jcmm.12655. The above article, published online on 10 August 2015 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Stefan N. Constantinescu; the Foundation for Cellular and Molecular Medicine; and John Wiley & Sons Ltd. The retraction has been agreed due to concerns raised by third parties. Specifically, the GAPDH blot shown in Figure 1D was found to have been later published elsewhere by the same author group but presented in a different scientific context. Further investigation by the publisher identified additional concerns, namely that the GAPDH bands in Figures 3C and 5B had been previously published by a different author group in a different scientific context. The clarification and materials provided by the authors were insufficient to address these concerns, and the authors did not supply the original data underlying the study upon request. Accordingly, the article has been retracted, as the editors consider its conclusions to be invalid. The authors have been informed of the retraction decision but were not available for final confirmation.

Identifiers

PMID42638411
PMCPMC13504235

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.